Apex Biotechnology (TPE:1733) EPS (Basic) : NT$1.60 (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology EPS (Basic)?

Apex Biotechnology's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$0.62. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.60.

Apex Biotechnology's EPS (Diluted) for the three months ended in Mar. 2025 was NT$0.62. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.60.

Apex Biotechnology's EPS without NRI for the three months ended in Mar. 2025 was NT$0.68. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.67.

During the past 12 months, Apex Biotechnology's average EPS without NRIGrowth Rate was 50.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -12.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Apex Biotechnology's highest 3-Year average EPS without NRI Growth Rate was 219.30% per year. The lowest was -79.30% per year. And the median was -8.50% per year.

Apex Biotechnology EPS (Basic) Historical Data

The historical data trend for Apex Biotechnology's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology EPS (Basic) Chart

Apex Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.95

2.03

1.82

1.16

1.28

Apex Biotechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.29	0.27	0.33	0.38	0.62

Apex Biotechnology EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Apex Biotechnology's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(127.998	-	0)	/	99.950
	=	1.28

Apex Biotechnology's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(62.027	-	0)	/	99.950
	=	0.62

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.60

Apex Biotechnology (TPE:1733) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Apex Biotechnology EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others. Company operates in Taiwan, USA, Italy, Austria, China , Others. Majority of revenue is from USA.

Apex Biotechnology Headlines

No Headlines